the microsampling blog / therapeutic drug monitoring

In some territories, which are listed in our website footer, our microsampling devices are supplied for therapeutic or IVD use as referenced in some of our content. Outside of those territories our devices are supplied for research use only (RUO).

microsampling to measure mAbs in children with inflammatory bowel disease

by James Rudge, PhD, Technical Director, Neoteryx | 6 min read

microsampling to measure mAbs in children with inflammatory bowel disease

An article by Marieke Zijlstra et al at Sanguin in the Netherlands published in the January 2021 issue of the Journal of Pediatric Gastroenterology and Nutrition reports on a pilot …

Read Story

using VAMS to measure drug level and renal function

by James Rudge, PhD, Technical Director, Neoteryx | 6 min read

using VAMS to measure drug level and renal function

An article by David J Marshall and Brian G Keevil et al at Wythenshawe Hospital and Nottingham Hospital, UK that was published in the July 2020 issue of Annals of …

Read Story

Mitra for measuring tacrolimus in transplant recipients in Norway

by James Rudge, PhD, Technical Director, Neoteryx | 8 min read

Mitra for measuring tacrolimus in transplant recipients in Norway

An article published by Nils T. Vethe et al in the October 2019 issue of Therapeutic Drug Monitoring, reported on the successful validation of 10 µL Mitra® devices from 26-27 …

Read Story

therapeutic drug monitoring for methadone maintenance programs

by Neoteryx | 2 min read

therapeutic drug monitoring for methadone maintenance programs

Methadone is one of the medications approved by the US Food and Drug Administration (FDA) for use in the treatment of Opioid Use Disorder (OUD). It is a long-acting opioid …

Read Story

TDM in Europe gets a boost from remote microsampling

by Neoteryx | 3 min read

TDM in Europe gets a boost from remote microsampling

Kang and Lee define TDM (therapeutic drug monitoring) as a clinical laboratory measurement of a particular drug in a patient’s bloodstream that, with proper medical interpretation and optimized and individualized …

Read Story
Prev All Posts Next
Content not found

Learn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!

search our blog

social media

subscribe to the blog

Fuel Your Innovative Approach to Science & Research. Subscribe to Our Microsampling Newsletter!

Get Our Newsletter

 

Get in Touch

 

Neoteryx, LLC

© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501

This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.

part-of-trajan-family-logo-white-text

 

Get To Know Us

Follow Us

Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC. 

hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.  

Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.